Dr Reddy’s proposes ‘Olymra’ rebrand in Delhi HC amid Novo Nordisk row

Dr Reddy’s told the Delhi High Court it plans to rebrand its diabetes drug amid a trademark dispute with Novo Nordisk over similarity with its drug Ozempic